Page last updated: 2024-11-03

rizatriptan and Headache Disorders

rizatriptan has been researched along with Headache Disorders in 1 studies

rizatriptan: structure given in first source; RN given refers to benzoate

Headache Disorders: Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS (based on characteristics of their headache symptoms) and SECONDARY HEADACHE DISORDERS (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research Excerpts

ExcerptRelevanceReference
"Chronic migraine (CM) is a common disorder, affecting 2% to 3% of the general population."1.34Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine. ( Cavalheiro, EA; Naffah-Mazzacoratti, Mda G; Peres, MF; Senne Soares, CA; Vieira, DS; Zukerman, E, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vieira, DS1
Naffah-Mazzacoratti, Mda G1
Zukerman, E1
Senne Soares, CA1
Cavalheiro, EA1
Peres, MF1

Other Studies

1 other study available for rizatriptan and Headache Disorders

ArticleYear
Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine.
    Headache, 2007, Volume: 47, Issue:6

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Glutamic Acid; Headache Disorders; Headache D

2007